Lipocine (LPCN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.56, -7.14% vs the prior close of $1.68.
- Volume 395.38K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
LPCN slides 7.1% to $1.56, a 52-week low. Closed at $1.56, -7.14% vs the prior close of $1.68. Day range $1.48–$1.66, opened at $1.66.
LPCN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — LPCN slides 7.1% to $1.56, a 52-week low
- Closed at $1.56, -7.14% vs the prior close of $1.68. Day range $1.48–$1.66, opened at $1.66.
- Volume was 395.38K shares, 0.2x its 50-day average of 2.25M — lighter than usual.
- Price is -25.7% vs its 50-day average ($2.10) and -63.4% vs its 200-day average ($4.26).
- 52-week range $1.48–$12.37; today's close sits at 1% of that range, 87.4% below the 52-week high.
Oct 15, 2026 — LPCN dips 0.6% to $1.68
- Closed at $1.68, -0.59% vs the prior close of $1.69. Day range $1.59–$1.69, opened at $1.64.
- Volume was 264.40K shares, 0.1x its 50-day average of 2.25M — lighter than usual.
- Price is -20.5% vs its 50-day average ($2.11) and -60.8% vs its 200-day average ($4.29).
- 52-week range $1.59–$12.37; today's close sits at 1% of that range, 86.4% below the 52-week high.
Oct 14, 2026 — LPCN jumps 4.3% to $1.69
- Closed at $1.69, +4.32% vs the prior close of $1.62. Day range $1.60–$1.71, opened at $1.69.
- Volume was 374.30K shares, 0.2x its 50-day average of 2.24M — lighter than usual.
- Price is -20.4% vs its 50-day average ($2.12) and -60.8% vs its 200-day average ($4.31).
- 52-week range $1.59–$12.37; today's close sits at 1% of that range, 86.3% below the 52-week high.
Oct 13, 2026 — LPCN dips 2.4% to $1.62, a 52-week low, 4 down days in a row
- Closed at $1.62, -2.41% vs the prior close of $1.66. Day range $1.61–$1.74, opened at $1.64.
- Volume was 500.40K shares, 0.2x its 50-day average of 2.24M — lighter than usual.
- Price is -24.0% vs its 50-day average ($2.13) and -62.6% vs its 200-day average ($4.33).
- 52-week range $1.59–$12.37; today's close sits at 0% of that range, 86.9% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — LPCN slides 3.5% to $1.66, a 52-week low, 3 down days in a row
- Closed at $1.66, -3.49% vs the prior close of $1.72. Day range $1.59–$1.77, opened at $1.71.
- Volume was 877.60K shares, 0.4x its 50-day average of 2.22M — lighter than usual.
- Price is -22.4% vs its 50-day average ($2.14) and -61.8% vs its 200-day average ($4.34).
- 52-week range $1.59–$12.37; today's close sits at 1% of that range, 86.6% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — LPCN slides 10.9% to $1.72, a 52-week low
- Closed at $1.72, -10.88% vs the prior close of $1.93. Day range $1.72–$1.90, opened at $1.89.
- Volume was 1.06M shares, 0.5x its 50-day average of 2.20M — lighter than usual.
- Price is -20.0% vs its 50-day average ($2.15) and -60.5% vs its 200-day average ($4.36).
- 52-week range $1.72–$12.37; today's close sits at 0% of that range, 86.1% below the 52-week high.
Oct 8, 2026 — LPCN slides 12.3% to $1.93, a 52-week low
- Closed at $1.93, -12.27% vs the prior close of $2.20. Day range $1.89–$2.05, opened at $2.05.
- Volume was 2.32M shares, 1.1x its 50-day average of 2.15M.
- Price is -10.5% vs its 50-day average ($2.16) and -55.8% vs its 200-day average ($4.37).
- 52-week range $1.81–$12.37; today's close sits at 1% of that range, 84.4% below the 52-week high.
Oct 7, 2026 — LPCN jumps 4.8% to $2.20 on 2813.0x normal volume
- Closed at $2.20, +4.76% vs the prior close of $2.10. Day range $2.07–$3.15, opened at $2.95.
- Volume was 105.84M shares, 2813.0x its 50-day average of 37.62K — unusually heavy trading.
- Price is +1.8% vs its 50-day average ($2.16) and -49.8% vs its 200-day average ($4.38).
- 52-week range $1.81–$12.37; today's close sits at 4% of that range, 82.2% below the 52-week high.
- That makes 3 straight gains.
- SEC filings that day: 8-K.
Oct 6, 2026 — LPCN rises 1.4% to $2.10
- Closed at $2.10, +1.45% vs the prior close of $2.07. Day range $2.07–$2.10, opened at $2.08.
- Volume was 12.80K shares, 0.3x its 50-day average of 37.95K — lighter than usual.
- Price is -2.7% vs its 50-day average ($2.16) and -52.2% vs its 200-day average ($4.39).
- 52-week range $1.81–$12.37; today's close sits at 3% of that range, 83.0% below the 52-week high.
Oct 5, 2026 — LPCN rises 1.0% to $2.07
- Closed at $2.07, +0.98% vs the prior close of $2.05. Day range $2.07–$2.13, opened at $2.07.
- Volume was 19.80K shares, 0.5x its 50-day average of 38.27K — lighter than usual.
- Price is -4.2% vs its 50-day average ($2.16) and -52.9% vs its 200-day average ($4.40).
- 52-week range $1.81–$12.37; today's close sits at 2% of that range, 83.3% below the 52-week high.
Oct 2, 2026 — LPCN dips 1.0% to $2.05, a 1-month low
- Closed at $2.05, -0.97% vs the prior close of $2.07. Day range $2.05–$2.13, opened at $2.08.
- Volume was 38.90K shares, 1.0x its 50-day average of 37.93K.
- Price is -5.1% vs its 50-day average ($2.16) and -53.5% vs its 200-day average ($4.40).
- 52-week range $1.81–$12.37; today's close sits at 2% of that range, 83.4% below the 52-week high.
LPCN latest news & SEC filings
Every SEC filing by or about LPCN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Higuchi John W. bought 9,037 shares at $2.15 (≈$19.43K) on Sep 29, 2026; now holds 225,395
- Higuchi John W. bought 15,970 shares at $2.23 (≈$35.61K) on Sep 30, 2026; now holds 241,365
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Higuchi John W. bought 12,561 shares at $2.16 (≈$27.13K) on Sep 28, 2026; now holds 216,358
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 21, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $190.10K (prior year $622.85K) (-69.5% vs Jun 30, 2025)
- Net income: -$2.62M (prior year -$2.21M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.32 (prior year -$0.41) (loss narrowed vs Jun 30, 2025)
Aug 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 30, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade LPCN
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 10, 2026, Feb 18, 2026. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.48% (largest 12.3%). That is a volatile stock.
- Liquidity: about 5.60M shares (≈$8.74M) trade per day on average.
- 52-week position: $1.56 vs a range of $1.48–$12.37 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: John W. Higuchi bought 12,561 shares on Sep 28, 2026.
- Latest filings: 8-K Oct 7, 2026; 8-K Sep 16, 2026; 8-K Sep 14, 2026.
- Share count: 8.24M shares outstanding (Aug 3, 2026), +52.1% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
LPCN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.66 | 1.66 | 1.48 | 1.56 | 395.38K |
| Oct 15, 2026 | 1.64 | 1.69 | 1.59 | 1.68 | 264.40K |
| Oct 14, 2026 | 1.69 | 1.71 | 1.60 | 1.69 | 374.30K |
| Oct 13, 2026 | 1.64 | 1.74 | 1.61 | 1.62 | 500.40K |
| Oct 12, 2026 | 1.71 | 1.77 | 1.59 | 1.66 | 877.60K |
| Oct 9, 2026 | 1.89 | 1.90 | 1.72 | 1.72 | 1.06M |
| Oct 8, 2026 | 2.05 | 2.05 | 1.89 | 1.93 | 2.32M |
| Oct 7, 2026 | 2.95 | 3.15 | 2.07 | 2.20 | 105.84M |
| Oct 6, 2026 | 2.08 | 2.10 | 2.07 | 2.10 | 12.80K |
| Oct 5, 2026 | 2.07 | 2.13 | 2.07 | 2.07 | 19.80K |
| Oct 2, 2026 | 2.08 | 2.13 | 2.05 | 2.05 | 38.90K |
| Oct 1, 2026 | 2.19 | 2.19 | 2.07 | 2.07 | 71.20K |
| Sep 30, 2026 | 2.14 | 2.25 | 2.08 | 2.20 | 31.40K |
| Sep 29, 2026 | 2.09 | 2.21 | 2.09 | 2.16 | 24.30K |
| Sep 28, 2026 | 2.07 | 2.21 | 2.06 | 2.09 | 34.40K |
| Sep 25, 2026 | 2.12 | 2.18 | 2.06 | 2.10 | 32.80K |
| Sep 24, 2026 | 2.10 | 2.18 | 2.08 | 2.09 | 32.60K |
| Sep 23, 2026 | 2.15 | 2.18 | 2.12 | 2.12 | 90.90K |
| Sep 22, 2026 | 2.13 | 2.22 | 2.12 | 2.16 | 64.30K |
| Sep 21, 2026 | 2.19 | 2.25 | 2.18 | 2.24 | 16.70K |
About Lipocine
Lipocine (LPCN) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SALT LAKE CITY, United States. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1535955.
LPCN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Michael Grissinger | Director | Aug 7, 2026 |
| John W. Higuchi | Director | Sep 30, 2026 |
| Jill M. Jene | Director | Jun 4, 2026 |
| Richard Dana Ono | Director | Jun 4, 2026 |
| Mahesh V. Patel | Chief Executive Officer | Jun 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Krista Fogarty | Principal Accounting Officer | Dec 19, 2025 |
| Mahesh V. Patel | Chief Executive Officer | Jun 30, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | John W. Higuchi | Buy | 12,561 | $2.16 |
| Sep 28, 2026 | John W. Higuchi | Buy | 12,561 | $2.16 |
| Sep 28, 2026 | John W. Higuchi | Buy | 12,561 | $2.16 |
| Sep 28, 2026 | John W. Higuchi | Buy | 12,561 | $2.16 |
| Apr 7, 2026 | John W. Higuchi | Buy | 40,000 | $2.03 |
| Apr 7, 2026 | John W. Higuchi | Buy | 40,000 | $2.03 |
| Apr 7, 2026 | John W. Higuchi | Buy | 40,000 | $2.03 |
| Apr 7, 2026 | John W. Higuchi | Buy | 40,000 | $2.03 |
| Apr 6, 2026 | John W. Higuchi | Buy | 123,000 | $2.05 |
| Apr 6, 2026 | John W. Higuchi | Buy | 123,000 | $2.05 |
| Apr 6, 2026 | John W. Higuchi | Buy | 123,000 | $2.05 |
| Apr 6, 2026 | John W. Higuchi | Buy | 123,000 | $2.05 |
| Apr 6, 2026 | Mahesh V. Patel | Buy | 25,000 | $2.03 |
| Apr 6, 2026 | Mahesh V. Patel | Buy | 25,000 | $2.03 |
| Apr 6, 2026 | Mahesh V. Patel | Buy | 25,000 | $2.03 |
LPCN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-9.63M | -1.69 | $-9.76M |
| Dec 31, 2024 | — | $8.35K | — | $-1.22M |
| Dec 31, 2023 | — | $-16.35M | -3.14 | $-11.87M |
| Dec 31, 2022 | $500.00K | $-10.76M | -2.15 | $-11.97M |
| Dec 31, 2021 | $16.14M | $-634.40K | -0.01 | $-4.41M |
Latest balance sheet: total assets $23.84M, total liabilities $2.07M, cash $4.98M (as of Jun 30, 2026).
LPCN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $2.13 |
| May 7, 2026 | 8-K Item 2.02 (results) | $2.39 |
| Mar 10, 2026 | 8-K Item 2.02 (results) | $8.11 |
| Feb 18, 2026 | 8-K Item 2.02 (results) | $9.33 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $2.64 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $3.08 |
| Mar 7, 2024 | 8-K Item 2.02 (results) | — |
| Jan 25, 2021 | 8-K Item 2.02 (results) | — |
| Nov 8, 2017 | 8-K Item 2.02 (results) | — |
| Aug 7, 2017 | 8-K Item 2.02 (results) | — |
| May 8, 2017 | 8-K Item 2.02 (results) | — |
| Mar 6, 2017 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on LPCN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.